- News>
- Companies & Commodities
Dr Reddy`s to appeal US Prilosec ruling
Mumbai, Oct 14: Dr Reddy`s Laboratories said on Monday it would appeal a US court`s decision that it infringed AstraZeneca`s patents on heartburn blockbuster Prilosec.
Mumbai, Oct 14: Dr Reddy's Laboratories said on Monday it would appeal a US court's decision that it infringed AstraZeneca's patents on heartburn blockbuster Prilosec.
A New York court ruled on Friday that the Indian company and two other generic drugmakers — Genpharm Inc and Andrx Corp — had infringed patents on Prilosec, a drug that generates almost $6 billion in annual sales.
A New York court ruled on Friday that the Indian company and two other generic drugmakers — Genpharm Inc and Andrx Corp — had infringed patents on Prilosec, a drug that generates almost $6 billion in annual sales.
The court ruled that a generic made by KUDCo, a unit of Germany's Schwarz Pharma AG, did not infringe the patents.
Dr Reddy's, like other Indian producers, targets the lucrative US market for generic drugs, or those that have lost their patent protection.
Its shares were down 0.62 per cent at Rs 775 rupees in early trade, while the Bombay index was flat. Its American Depositary Receipts ended 3.13 per cent higher at $17.48 on Friday. Bureau Report